HNRNPA1 and urinary bladder cancer: Additionally, RBMX inhibits aerobic glycolysis via hnRNP-A1-dependent PKM alternative splicing, and it counteracts the aggressive phenotype induced by PKM2 overexpression in bladder cancer cells (31).